Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects. | J Med Chem;66(6): 3746-3784, 2023 03 23. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects.

Smith, Maree T; Kong, Dehui; Kuo, Andy; Imam, Mohammad Z; Williams, Craig M.

J Med Chem ; 66(6): 3746-3784, 2023 03 23.

Article in En | MEDLINE | ID: mdl-36856340

Subject(s)

Analgesia; Analgesics, Opioid; Animals; Analgesics, Opioid/adverse effects; Receptors, Opioid, mu; Receptors, Opioid, delta; Ligands; Pain/drug therapy; Morphine

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesia / Analgesics, Opioid Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2023 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesia / Analgesics, Opioid Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2023 Document type: Article Country of publication: United States